A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs

► E105K mutation in influenza B virus NA confers reduced susceptibility to NA inhibitors. ► Residue 105 is located far from the enzymatic active site of NA. ► E105K mutation may destabilize the tetrameric form of NA.